ArticleBMC pediatrics2022

The effect of decitabine-combined minimally myelosuppressive regimen bridged allo-HSCT on the outcomes of pediatric MDS from 10 years' experience of a single center.

Junyan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.